The pirates come ashore

German Pirate Party’s strong showing in the May elections is a sign that anti-IPR movements resonate with the people

Patent issues delaying Ebola cure

Canada's exclusive licensing rights of its Ebola patent to a US firm are holding up global development of a vaccine

Sub-standard drugs bigger problem than counterfeit drugs: health activists

Problem of poor quality drugs cannot be solved with technology alone, they say

Say cheese to Brussels

What Durban did not discuss

IPRs are blocking access to mitigation and adaptation technologies. India offers a way out

New endosulfan ploy

Industry is sidestepping issues by pitching the proposed UN ban on endosulfan as the battle between generics and patented pesticides

Predatory EU pacts

EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global

Letters

WTO gives India a clean chit

Apex trade regulator finds nothing amiss in India's intellectual property laws after exhaustive review

A people’s festival to protest CBD conference

Non-profits to represent united resolve to protect the country’s natural wealth and bio-cultural heritage from powerful economic interests

Environment ministry rapped

Parliament committee says serious inadequacies in afforestation, biodiversity programmes

Biotech industry has a new patron

Department of Biotechnology is playing venture capitalist to private companies to push biotech research in agriculture

Unholy smoke!

Inclusion of intellectual property in bilateral investment agreements is injurious to the health of developing nations

Testing the CL route

Roche’s Herceptin will be a test case for government and generics industry as India readies to issue compulsory licences for life-saving drugs

EU threat to farmers

Free trade pact with EU will have a severe impact on Indian agriculture, specially the dairy sector

Fall of a premier institute

Amid funds siphoning allegations, future of National Institute of Pharma Education seems bleak

Trade barred

Countries protect their renewable energy equipment. Exporting nations see it as trade barrier  

Indian company gets licence to manufacture and sell patented cancer drug

This is the first-ever compulsory licence given to a generic drug company

Wooing the judges, openly

There is conflict of interest as US patent owners schedule meetings with Indian judiciary and patent regulators

US pharma strikes back

Upset by the Supreme Court’s endorsement of India’s patent law, the American drug industry is lobbying with Obama to tighten the …

US piles on the pressure

Patent law, domestic content rules in solar and ICT policy come under attack

Big step for biocultural rights

The Nagoya Protocol promotes community stewardship of genetic resources. India needs to foster this

Coffins for the EU Delegation in Delhi

Health activists protest against the EU-India investment treaty under negotiation now

News 360° - Briefs

A treaty too many

India is learning that there is a heavy price to be paid for the large number of bilateral investment treaties, or BITs, it has signed in the …